Cary Street Partners Financial LLC Makes New $11.48 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Cary Street Partners Financial LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 22,688 shares of the healthcare conglomerate's stock, valued at approximately $11,477,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Brown Advisory Inc. raised its stake in UnitedHealth Group by 1.9% during the 4th quarter. Brown Advisory Inc. now owns 707,545 shares of the healthcare conglomerate's stock worth $357,919,000 after acquiring an additional 13,157 shares during the period. Baird Financial Group Inc. lifted its stake in shares of UnitedHealth Group by 4.6% during the 4th quarter. Baird Financial Group Inc. now owns 416,151 shares of the healthcare conglomerate's stock valued at $210,515,000 after buying an additional 18,290 shares in the last quarter. Banque Transatlantique SA purchased a new stake in UnitedHealth Group in the 4th quarter worth $1,264,000. Banque de Luxembourg S.A. purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at about $7,716,000. Finally, Bayesian Capital Management LP purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $2,887,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $398.72 on Monday. UnitedHealth Group Incorporated has a 52 week low of $393.11 and a 52 week high of $630.73. The company has a market capitalization of $362.92 billion, a PE ratio of 25.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The stock's fifty day moving average is $495.85 and its two-hundred day moving average is $528.18. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the business earned $6.91 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.11%. UnitedHealth Group's payout ratio is currently 35.18%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. KeyCorp cut their price objective on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Raymond James reiterated a "strong-buy" rating and issued a $540.00 price target (down from $635.00) on shares of UnitedHealth Group in a report on Monday, April 21st. HSBC reissued a "hold" rating and set a $490.00 price objective on shares of UnitedHealth Group in a report on Tuesday, April 22nd. JPMorgan Chase & Co. decreased their target price on UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Finally, Erste Group Bank downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Four research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.